Zalcitabine
Zalcitabine is a nucleoside reverse transcriptase inhibitor (NRTI) used as an antiviral medication. It is a synthetic analogue of the naturally occurring nucleoside deoxycytidine. Zalcitabine inhibits the reverse transcriptase enzyme, which is essential for the replication of retroviruses such as HIV.
Lab products found in correlation
5 protocols using zalcitabine
Remdesivir, Zidovudine, and Zalcitabine Cytotoxicity
Mitochondrial Dysfunction Modulation Protocol
Compound Solubilization Protocol
Evaluating Anti-HIV Drug Efficacy in Patient Samples
Twelve HIV-1 inhibitors were used in this study, including six nucleoside reverse-transcriptase inhibitors (NRTIs): Didanosine (DDI), Stavudine (D4T), Zidovudine (AZT), Zalcitabine (DDC), Emtricitabine (FTC), Abacavir Sulfate (ABC), four non-nucleoside reverse transcriptase inhibitors (NNRTIs): Nevirapine (NVP), Etravirine (ETR), Dapivirine (DPV), Rilpivirine (RPV), and two protease inhibitors (PIs): Nelfinavir (NFV) and Lopinavir (LPV), which were purchased commercially from Selleckchem (Shanghai, China).
Dexrazoxane-Protein Interaction Assay
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!